Has Katherine Labiner received payments from drug or device companies?

Yes. Drug and device makers reported $285,017 in general payments to Katherine Labiner across 1,082 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Katherine Labiner did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Katherine Labiner come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Katherine Labiner

Epilepsy · Austin, TXNPI 1861788465

Payments from drug & device makers

$285,017in general payments, 2019–2025

Across 1,082 payments — averaging $263.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$66K
Acadia Pharmaceuticals Inc$54K
Biohaven Pharmaceutical Holding Company Ltd.$49K
UCB, Inc.$29K
Jazz Pharmaceuticals Inc.$17K
Aucta Pharmaceuticals, Inc.$16K
plus $54K from 54 others

$30,228in research payments, 2019–2025

Across 6 payments — averaging $5037.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$30K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	19	$66,305
Acadia Pharmaceuticals Inc	132	$53,830
Biohaven Pharmaceutical Holding Company Ltd.	10	$48,959
UCB, Inc.	144	$29,351
Jazz Pharmaceuticals Inc.	54	$16,821
Aucta Pharmaceuticals, Inc.	26	$15,729
Neurelis, Inc.	87	$11,580
Otter Pharmaceuticals, LLC	28	$11,056
Aquestive Therapeutics, Inc.	51	$10,926
UCB SA	2	$6,613
SK Life Science, Inc.	98	$4,295
Greenwich Biosciences, Inc.	20	$816
Neuropace, Inc.	21	$801
Upsher-smith Laboratories LLC	21	$766
Biocodex, Inc.	16	$698
Livanova USA, Inc.	35	$697
Tris Pharma Inc	35	$645
Supernus Pharmaceuticals, Inc.	51	$585
Takeda Pharmaceuticals U.S.A., Inc.	31	$447
Corium, LLC	18	$347
Ironshore Pharmaceuticals Inc.	22	$328
Eisai Inc.	13	$257
Amgen	12	$226
Pyros Pharmaceuticals, Inc.	9	$217
Zogenix Inc.	10	$208
Ipsen Biopharmaceuticals, Inc	9	$200
Neos Therapeutics, LP	12	$187
Abbott	2	$183
Sunovion Pharmaceuticals Inc.	11	$149
Sumitomo Pharma America, Inc.	9	$139
Biogen	6	$130
Biohaven Pharmaceuticals, Inc.	5	$127
GSK	1	$122
Octapharma USA, Inc.	5	$99
Vertical Pharmaceuticals, LLC	4	$89
Immedica Pharma US, Inc.	3	$83
AbbVie	4	$78
Collegium Pharmaceutical, Inc.	4	$76
Saol Therapeutics Inc.	4	$76
Antares Pharma, Inc.	3	$61
Johnson & Johnson	2	$55
Springworks Therapeutics, Inc.	2	$53
Merz Pharmaceuticals, LLC	2	$52
Mallinckrodt Hospital Products Inc.	2	$45
Amneal Pharmaceuticals LLC	3	$41
Sanofi	2	$37
Avion Pharmaceuticals	2	$35
ITF Therapeutics LLC	1	$35
Piramal Critical Care	2	$34
Nobelpharma America, LLC	2	$34
Catalyst Pharmaceuticals, Inc.	2	$33
Azurity Pharmaceuticals, Inc.	1	$30
PTC Therapeutics, Inc.	1	$28
Arbor Pharmaceuticals, Inc.	2	$27
Tersera Therapeutics LLC	1	$25
E.r. Squibb & Sons, L.L.C.	1	$25
Adlon Therapeutics L.p.	1	$24
Noven Therapeutics, LLC	1	$23
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)	1	$21
Novartis	1	$19

How this compares

$285,017 in reported general payments places this provider in the 90th percentile of 36 epilepsy providers in Texas.

See all epilepsy providers in Texas →

Other epilepsy in Austin

Karen KeoughAustin$1.1M
Daniel GustkeyAustin$12K
Andrew LinAustin$42
Bernhard SuterHouston$694K
Jay HarveyDallas$279K
Anuranjita NayakHouston$185K
Leonel EstofanEdinburg$108K
Linda LearySan Antonio$78K
Charles SzaboSan Antonio$69K
Erin FiedlerDallas$9K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →